CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 91 enrolled
Drug / intervention
Indacaterol 27.5 mcg +5 moredrug
Likely dose
Indacaterol 27.5 mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01959412
NCT01959412Phase 2Completed
CompareCT.gov

A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma

Novartis Pharmaceuticals·interventional·Posted Oct 10, 2013·Updated May 6, 2015

In Brief

A Phase 2 clinical trial evaluating Indacaterol 27.5 mcg, Indacaterol 37.5, and 4 other interventions for Asthma. Completed, enrolled 91 participants across 12 sites.

Detailed Summary

The purpose of this study is to determine the efficacy of indacaterol 55µg once daily (and 27.5 µg twice) in QVA149 compared to 75 µg indacaterol monotherapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 10, 2013
Enrollment StartNov 1, 2013
Primary CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 12.7 years ago

Interventions

Indacaterol 27.5 mcgdrug

indacaterol 27.5 mcg twice daily inhaled once via inhaler

Indacaterol 37.5drug

Indacaterol 37.5 mcg once daily, inhaled once via inhaler

Indacaterol 55 mcgdrug

Indacaterol 55 mcg once daily, inhaled once via inhaler

Indacaterol 75 mcgdrug

Indacaterol 75 mcg once daily, inhaled once via inhaler

Indacaterol 150 mcgdrug

Indacaterol 150 mcg once daily, inhaled once via inhaler

Placebodrug

Placebo to indacaterol once or twice daily (depending on assigned sequence) via inlaher